SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 149 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 4.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $115,000 | 0.0% | 11,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $115,000 | -2.5% | 11,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $118,000 | -4.1% | 11,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $123,000 | -24.1% | 11,100 | -7.5% | 0.00% | -50.0% |
| Q4 2016 | $162,000 | -19.8% | 12,000 | -38.5% | 0.00% | 0.0% |
| Q1 2016 | $202,000 | -50.4% | 19,500 | -15.2% | 0.00% | -60.0% |
| Q4 2015 | $407,000 | -9.8% | 23,000 | +1.3% | 0.01% | -16.7% |
| Q3 2015 | $451,000 | +26.0% | 22,700 | +4.1% | 0.01% | +50.0% |
| Q2 2015 | $358,000 | +9.5% | 21,800 | +3.8% | 0.00% | 0.0% |
| Q1 2015 | $327,000 | -0.6% | 21,000 | -11.4% | 0.00% | 0.0% |
| Q4 2014 | $329,000 | +94.7% | 23,700 | -8.8% | 0.00% | +100.0% |
| Q3 2014 | $169,000 | -4.0% | 26,000 | +2.0% | 0.00% | -33.3% |
| Q2 2014 | $176,000 | -6.9% | 25,500 | -3.8% | 0.00% | 0.0% |
| Q1 2014 | $189,000 | -16.7% | 26,500 | +10.4% | 0.00% | -25.0% |
| Q4 2013 | $227,000 | +54.4% | 24,000 | +2.1% | 0.00% | +33.3% |
| Q3 2013 | $147,000 | +0.7% | 23,500 | +9.3% | 0.00% | 0.0% |
| Q2 2013 | $146,000 | – | 21,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
| NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
| IFP Advisors, Inc | 384 | $7,000 | 0.00% |
| GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |